Anaemia is common in patients with end-stage liver disease. Pre-operative anaemia is associated with greater mortality after major surgery. We analysed the association of pre-operative anaemia (World Health Organization classification) with survival and complications after orthotopic liver transplantation using Cox and logistic regression models. We included patients undergoing their first orthotopic liver transplantation between 2004 and 2016. Out of 599 included patients, 455 (76%) were anaemic before transplantation. Pre-operative anaemia was not associated with the survival of 485/599 (81%) patients to 1 year after liver transplantation, OR (95%CI) 1.04 (0.64-1.68), p = 0.88. Pre-operative anaemia was associated with higher rates of intra-operative blood transfusions and acute postoperative kidney injury on multivariable analysis, OR (95%CI) 1.70 (0.82-2.59) and 1.72 (1.11-2.67), respectively, p < 0.001 for both. Postoperative renal replacement therapy was associated with pre-operative anaemia on univariate analysis, OR (95%CI) 1.87 (1.11-3.15), p = 0.018.
Introduction
Orthotopic liver transplantation can cure patients suffering from acute or chronic liver failure, the outcome of which is associated with several patient variables, such as age, diabetes mellitus, postoperative acute kidney injury and peritonitis [1] [2] [3] [4] [5] . Survival to one postoperative year is about 80% [6] .
Pre-operative anaemia is present in about one-third of patients who undergo major surgery and it is associated with subsequent morbidity and mortality [7, 8] . The incidence of anaemia before orthotopic liver transplantation is as high as 75%, but it is uncertain whether it is associated with outcome [6, 9, 10] .
Packed red blood cells are often transfused to correct anaemia, yet transfusion is associated with adverse outcomes and may cause increased morbidity and mortality after cardiac, orthopaedic and abdominal surgery [11] [12] [13] [14] [15] [16] .
Transfusion is also associated with adverse outcomes after liver transplantation [2, 17] .
Our primary aim was to evaluate the association of anaemia before orthotopic liver transplantation with survival to 1 year and secondarily survival to the end of follow-up. We were also interested in the associations of peri-operative variables, including blood transfusion, with these outcomes and their interactions with preoperative anaemia.
Methods
The ethics committee of the Medical University of Vienna approved this study. We studied patients admitted to our hospital for orthotopic liver transplantation between January 2004 and December 2016. We did not include We determined the association of WHO-defined preoperative anaemia (< 13 g.dl À1 for men and < 12 g.dl À1 for women) with 1-year survival. We performed secondary analyses of the association of the severity of anaemia in men and women with survival, categorised as mild (11-13 g.dl À1
and 10-12 g.dl À1 , respectively), moderate (8-11 g.dl À1 and 8-10 g.dl À1 , respectively) or severe (< 8 g.dl À1 ) [18] . The secondary outcome was survival to the end of 2017.
We assessed the associations of pre-operative variables other than anaemia with outcomes such as age;
sex; body mass index; model for end-stage liver disease (MELD) score; coronary artery disease; chronic obstructive pulmonary disease; diabetes mellitus; and pre-operative hospitalisation. We defined coronary artery disease as the presence of coronary atherosclerosis (> 50% stenosis of a coronary artery), or previous percutaneous coronary intervention. We defined preoperative hospitalisation as inpatient treatment for at least 3 days before liver transplantation, or repeated within one postoperative week [19] . We defined acute kidney injury with standard criteria [20] . We categorised patients by whether they had renal replacement therapy within one postoperative week.
We did not calculate sample size for this retrospective 
Results
We studied 599/659 patients, most of whom were anaemic before orthotopic liver transplantation ( Table 1 and Table S1 ). The mean (SD) pre-operative haemoglobin concentration was 13.8 (1.1) g.dl À1 for 144 patients who were not anaemic and 10.2 (1.5) g.dl À1 for 455 anaemic patients. Anaemic patients were younger but with worse liver disease, for which they were more Figure 1 Survival after orthotopic liver transplantation of 599 patients, categorised by pre-operative haemoglobin concentration as not anaemic in 144 patients (green line); or anaemic in 455 patients (red line). Corresponding 95%CIs are shown as green or red areas, respectively. There were no statistically significant differences during the first year or for overall survival, p = 0.88 and p = 0.20, respectively. often hospitalised, and they were more likely to have diabetes ( Table 1 ).
There were 114/599 (19%) deaths in the first postoperative year from infection in 36 (32%); bleeding in 15 (13%); graft failure in 11 (10%); multi-organ failure in 9 (8%); cardiovascular events in 6 (5%); cancer in 5 (4%); surgical complications in 5 (4%); disease recurrence in 3 (3%); respiratory failure in 3 (3%); and unknown in 19 (17%).
The median (IQR [range]) follow-up was 4 (1-9 [0-15]) years, and the median survival (95%CI) was 11 (8) (9) (10) (11) (12) (13) years. There were 235 deaths during follow-up from infection in 51 (22%); bleeding in 20 (9%); graft failure in 18 (8%); multiorgan failure in 15 (6%); cardiovascular events in 12 (5%); cancer in 11 (5%); surgical complications in 5 (2%); disease recurrence in 13 (6%); respiratory failure in 5 (2%); and unknown in 84 (36%).
Survival to one postoperative year and to the end of follow-up was not associated with anaemia ( Fig. 1 ), but was associated with a number of variables (Tables 2 and   3 
Discussion
We found that pre-operative anaemia was not associated with survival after liver transplantation. Pre-operative anaemia was associated with peri-operative blood transfusion and postoperative acute kidney injury.
Pre-operative anaemia is associated with worse outcome after major cardiac and non-cardiac surgery [7, 14, 22] . Some previous studies have reported an association of pre-operative anaemia with survival after liver transplantation [10] , while others have not [6] . Pre-operative anaemia may be indirectly associated with survival after liver transplantation, as survival is worse after blood transfusion [16, 17, 23] . The decision to transfuse blood is affected by variables such as the MELD score or cold ischaemia time, which are associated with impaired coagulation, as well as haemoglobin concentration. Thus, the univariate association of the MELD score with survival to one postoperative year in our cohort is consistent with its association with coagulation.
Pre-operative anaemia was associated with acute postoperative kidney injury in our cohort. We assume that preoperative anaemia was also associated with renal replacement therapy, with which anaemia was associated in isolation from other variables. Other studies have reported contradictory evidence for association of anaemia with renal replacement therapy after liver transplantation, which in turn is associated with worse survival [2, 6, 24] .
Acute and chronic gastro-intestinal haemorrhage, malnutrition, iron deficiency, folate or vitamin B12 deficiency and suppression of bone marrow are mainly responsible for anaemia in end-stage liver disease patients [9, [25] [26] [27] [28] . Increasing pre-operative haemoglobin [29] [30] [31] [32] . We think that patients awaiting liver transplantation might benefit from pre-operative iron supplementation, which needs to be investigated in prospective randomised studies.
Unfortunately, due to insufficient diagnostic data, the cause of anaemia remains unknown in most of our patients.
Iron status was only available for approximately half the study population. Further limitations of our study are the retrospective and monocentric design, which might limit the generalisability of our results. We analysed survival after operations that spanned 12 years, during which medical interventions have changedsuch as the use of hydroxyethyl starchas has general population survival, but date of surgery was not associated with observed survival in our cohort [33, 34] .
In conclusion, pre-operative anaemia was not associated with survival after liver transplantation. However, anaemia was associated with blood transfusion, postoperative acute kidney injury and renal replacement therapy.
